Ruiming Zhou left the role of Director at VitaNova Life Sciences Corp, effective March 12, 2026. As of November 14, 2026, VitaNova Life Sciences Corp has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from February 25, 2026 to March 18, 2026, naming 1 appointment and 1 departure (Form 8-K, March 18, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like VitaNova Life Sciences Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
VitaNova Life Sciences Corp reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-02-25 to 2026-03-18. They name 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as VitaNova Life Sciences Corp files it.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-03-18 | Out | Director | 2026-03-12 | 8-K, 2026-03-18 | |
| 2026-02-25 | In | Director | 2026-02-19 | 8-K, 2026-02-25 |
Selling to them or working with them? See who runs VitaNova Life Sciences Corp now and the warning signs.
Free to see. No signup.
Watch VitaNova Life Sciences Corp
Get an email when VitaNova Life Sciences Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on VitaNova Life Sciences Corp?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on VitaNova Life Sciences Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on VitaNova Life Sciences Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
2 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Why did they leave? What the filings say
VitaNova Life Sciences Corp's filings state no reason for the departures below. Where a filing gives none, it says so here; nothing is inferred.
- Ruiming Zhou, Director (filed 2026-03-18): the filing states no reason.
Who leads VitaNova Life Sciences Corp, as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Ruiming Zhou, departure reported, effective 2026-03-12 (filed 2026-03-18). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on VitaNova Life Sciences Corp: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at VitaNova Life Sciences Corp, with the record behind each one.
Find candidates like Director at VitaNova Life Sciences CorpEvery change, in the filing's words
Departing: Ruiming Zhou, Director, effective 2026-03-12
Effective as of March 12, 2026, Ruiming Zhou resigned from her position as the director of VitaNova Life Sciences Corporation (the "Company").
Appointed: Steve Niu, Director, effective 2026-02-19
Effective February 19, 2026, the Board of Directors of VitaNova Life Sciences Corporation (the " Company ") appointed Steve Niu, the Company's Chief Financial Officer, to serve as a director of the Company until the Company's next annual meeting of stockholders or until his earlier resignation or removal .
- Mr. Niu will not receive any additional compensation for his service as a director.
- Mr. Niu, age 64, has been our Chief Financial Officer since January 2024.
- Prior to joining the Company, Mr. Niu served as the President of Triangle Accounting, Inc. from 2001 to 2024.
- He specializes in U.S. federal and state taxation, international taxation, U.S. and Chinese regulatory compliance and foreign income consulting.
- He earned his Ph.D. and Master's degree in Computer Information Systems from Carleton University, Canada, in 2001 and 1998, respectively.
- In 1984, he graduated from Xi'an University of Science and Technology with a Bachelor's degree in Mining Engineering.
- Our Board of Directors of the Company has determined that Mr. Niu doesn't qualify as an independent director, as defined under the applicable corporate governance standards of Nasdaq.
Tools for this story
Each opens in a new tab, filled in for VitaNova Life Sciences Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
